Navigation Links
BioMS Medical to present at BioCentury Conference
Date:3/24/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, March 24 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the BioCentury "Future Leaders in the Biotech Industry" Conference in New York.

WHEN: Thursday March 27th at 2:00pm (Eastern Time)

WHERE: The Millennium Broadway Hotel & Conference Center, New York

About BioCentury "Future Leaders in the Biotech Industry" Conference

-------------------------------------------------------------------- This conference offers senior investment professionals an opportunity to review investment opportunities: companies making the transition from the private to public equity markets, as well as public plays positioned to move between tiers based on value or milestones. For more information visit: http://www.biocentury.com/BCApp/BioCenturyCommon/BCConferences.aspx?ss=1

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking st
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical Announces 2007 Year End Results
2. BioMS Medical to present at BIO CEO & Investor Conference
3. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
4. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
5. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
6. BioMS Medical announces third quarter 2007 results
7. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
8. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. BioMS Medical to present at BioContact 2007
10. BioMS Medical announces its intention to renew a normal course issuer bid
11. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...on for the proposed Wisconsin Institute for Discov...roposal to build a $375 million interdisciplinary ...characterized as a response to California, where v...und human embryonic stem cell research. , ,Make no...what will happen inside the Wisconsin Institute fo...
...was a big week for Wisconsin. , ,Though California...und $3 billion in new stem-cell research in the wa...s and restricts federal government-associated rese...uch research was pioneered. , ,Wisconsin is also t... and the Wisconsin Alumni Research Foundation (WAR...
...ec pal of mine has observed that many IT shops g...rse, an acronym. While I have been known to scramb...one is pretty clever. MUD stands for machine und...is that almost anybody can start a little computin...rn for reliability, security, connectivity or comp...
...hanksgiving is officially over, we are into the ho... ,For those of you following the biotech IPO marke...e year as everything really closes down in the pub...dle of December. New activity won,t be happening u...ke a promising and valiant biotech IPO market has ...
Other Biology Technology:Doyles proposal is about more than keeping pace with California 2Doyles proposal is about more than keeping pace with California 3Third coast of biotechnology makes strong showing at VC conference 2Third coast of biotechnology makes strong showing at VC conference 3Third coast of biotechnology makes strong showing at VC conference 4Third coast of biotechnology makes strong showing at VC conference 5Is your IT stuck in the MUD? 2Is your IT stuck in the MUD? 3Midwest life-science company Perrigo globalizes under the radar 2Midwest life-science company Perrigo globalizes under the radar 3Midwest life-science company Perrigo globalizes under the radar 4Midwest life-science company Perrigo globalizes under the radar 5
(Date:7/25/2008)...- Children born with hydrocephalus, or "water on t...fluid away from the brain to reduce harmful pressu...of shunt infection in children is very high for a ...ld through another surgery to replace the shunt, b...tional neurological complications and an increased...
(Date:7/24/2008)...ional team led by Massachusetts General Hospital (...ol for genomic research and medicine a robust met...et particular DNA sequences for inactivation or re...the researchers describe an efficient, publicly av...nucleases (ZFNs), which can be used to induce spec...
(Date:7/24/2008)... new study by researchers from Columbia University...f the most challenging issues in infant health and...or countries. In these settings, HIV-infected mot...r their infants, they should exclusively breast-fe... after birth. But according to the study conducted...
(Date:7/24/2008)... UC Irvine researchers have found a molecular lin...nd metabolism. The discovery reveals new possibili...her related diseases. , Paolo Sassone-Corsi, Dis...d his colleagues have identified that an essential...rcadian rhythms, works in balance with another pro...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Consortium develops new method enabling routine targeted gene modification 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Wanted 3A 40 000 more health IT professionals 2949 1Wanted 3A 40 000 more health IT professionals 2949 2Wanted 3A 40 000 more health IT professionals 2949 3Ovarian cancer stem cells identified characterized 2947 1Ovarian cancer stem cells identified characterized 2947 2Inherited cancer mutation is widespread in America 2945 1Inherited cancer mutation is widespread in America 2945 2Childrens Hospital of Michigan Awarded Prestigious Magnet Status 17132 1Childrens Hospital of Michigan Awarded Prestigious Magnet Status 17132 2
...e caused by arterial blockages related to diabetes...ns ?are occurring at an alarming rate. Yet physici...them may be preventable, according to the Internat...nly disfiguring and life-threatening, but are more...on, which is the reestablishment of blood supply. ...
...SX: NRM) is pleased to announce that Neurobiology ... medical journals in the fields of gerontology and...a publication on the preclinical development of tr...ed?, including efficacy results in a mouse model o...sents a potential new class of therapeutic agent a...
...y Professor of Psychology Dr. Jeffrey Mogil shows ...d but unproven even among higher primates, is also... online June 29 in the journal Science, Professor ...lleagues in the Pain Genetics Lab at McGill Univer...t is, familiar to each other) and able to see one ...
...f Texas M. D. Anderson Cancer Center have signific...a cell begins the process of self-destruction - an...argeted cancer therapies. , , In the June 30 is...hat a natural "brake" exists in a cell to prevent ...eath, and they say that optimal anti-cancer therap...
Other Biology News:Epidemic of unneeded amputations 2Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging 2Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging 3Researchers find molecular 'brake' to cell death 2Researchers find molecular 'brake' to cell death 3
Request Info
Bovine Serum Albumin Heat Shock Diagnostic Grade Powder
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed
MpV17 transgene, murine homolog, glomerulosclerosis
Biology Products: